Labcorp (NYSE:LH) Updates FY 2026 Earnings Guidance

Labcorp (NYSE:LH) issued an update on its FY 2026 earnings guidance on Friday. The company provided earnings per share guidance of 18.100-18.550 for the period, compared to the consensus earnings per share estimate of 18.340. The company issued revenue guidance of $14.7 billion-$14.8 billion, compared to the consensus revenue estimate of $14.7 billion.

Analyst Upgrades and Downgrades

LH has been the subject of a number of research reports. Robert W. Baird set a $352.00 price target on Labcorp in a research report on Friday, July 31st. Weiss Ratings upgraded Labcorp from a “buy (b-)” rating to a “buy (b)” rating in a research report on Friday, July 24th. Wall Street Zen upgraded shares of Labcorp from a “hold” rating to a “buy” rating in a research report on Sunday, July 12th. JPMorgan Chase & Co. increased their target price on Labcorp from $330.00 to $360.00 and gave the company an “overweight” rating in a research report on Monday, August 3rd. Finally, Piper Sandler upped their price target on shares of Labcorp from $300.00 to $309.00 and gave the stock a “neutral” rating in a research report on Tuesday, August 4th. Nine analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $336.36.

Labcorp Stock Down 0.5%

Shares of NYSE:LH opened at $323.04 on Friday. Labcorp has a 52-week low of $244.52 and a 52-week high of $341.80. The stock has a market cap of $26.20 billion, a P/E ratio of 26.72, a PEG ratio of 1.84 and a beta of 0.88. The business has a fifty day moving average of $313.65 and a two-hundred day moving average of $282.90. The company has a quick ratio of 1.53, a current ratio of 1.80 and a debt-to-equity ratio of 0.69.

Labcorp (NYSE:LH) last issued its earnings results on Thursday, July 30th. The medical research company reported $4.99 EPS for the quarter, topping analysts’ consensus estimates of $4.78 by $0.21. Labcorp had a net margin of 6.99% and a return on equity of 16.74%. The company had revenue of $3.73 billion for the quarter, compared to the consensus estimate of $3.71 billion. During the same period in the previous year, the firm earned $4.35 earnings per share. Labcorp’s quarterly revenue was up 5.8% compared to the same quarter last year. Labcorp has set its FY 2026 guidance at 18.100-18.550 EPS. On average, research analysts expect that Labcorp will post 18.32 earnings per share for the current year.

Labcorp Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, September 11th. Shareholders of record on Friday, August 28th were paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend was Friday, August 28th. Labcorp’s dividend payout ratio (DPR) is 23.82%.

Insiders Place Their Bets

In other news, EVP Amy Summy sold 924 shares of the company’s stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $306.74, for a total value of $283,427.76. Following the transaction, the executive vice president directly owned 6,956 shares in the company, valued at approximately $2,133,683.44. This represents a 11.73% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Kerrii Anderson sold 3,000 shares of Labcorp stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $318.02, for a total transaction of $954,060.00. Following the completion of the sale, the director owned 6,563 shares of the company’s stock, valued at $2,087,165.26. This trade represents a 31.37% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 8,919 shares of company stock worth $2,826,593. Insiders own 0.84% of the company’s stock.

Labcorp Company Profile

Labcorp (NYSE: LH), formerly Laboratory Corporation of America Holdings, is a global life sciences and laboratory services company headquartered in Burlington, North Carolina. The company provides diagnostic testing and related services to physicians, hospitals, health systems, employers, government agencies and consumers.

Its diagnostics business offers routine and specialty laboratory testing, including molecular, genetic, oncology, women’s health, infectious disease and pathology services.